667
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The impact of systemic methotrexate and surgical management on fertility preservation in tubal ectopic pregnancy among Saudi women

ORCID Icon, ORCID Icon, , , & ORCID Icon
Article: 2241106 | Received 30 Sep 2022, Accepted 21 Jul 2023, Published online: 27 Jul 2023

References

  • Bakken IJ, Skjeldestad FE. Time trends in ectopic pregnancies in a Norwegian county 1970–2004—a population based study. Hum Reprod. 2006;21(12):3132–3136. doi: 10.1093/humrep/del289.[PMC]]
  • Garzon S, Laganà AS, Pomini P, et al. Laparoscopic reversible occlusion of uterine arteries and cornuostomy for advanced interstitial pregnancy. Minim Invasive Ther Allied Technol. 2018;4:1–4.
  • Tay JI, Moore J, Walker JJ. Ectopic pregnancy. BMJ. 2000;320(7239):916–919. doi: 10.1136/bmj.320.7239.916.
  • Mol F, Strandell A, Jurkovic D, et al. The ESEP study: salpingostomy versus salpingectomy for tubal ectopic pregnancy; the impact on future fertility: a randomised controlled trial. BMC Womens Health. 2008;8:11. doi: 10.1186/1472-6874-8-11.
  • Chen L, Zhu D, Wu Q, et al. Fertility outcomes after laparoscopic salpingectomy or salpingotomy for tubal ectopic pregnancy: a retrospective cohort study of 95 patients. Int J Surg. 2017;48:59–63. doi: 10.1016/j.ijsu.2017.09.058.
  • Yousefnezhad A, Pirdehghan A, Roshandel Rad M, et al. Comparison of the pregnancy outcomes between the medical and surgical treatments in tubal ectopi pregnancy. IJRM. 2018;16(1):31–34. doi: 10.29252/ijrm.16.1.31.
  • Sagiv R, Debby A, Feit H, et al. The optimal cutoff serum level of human chorionic gonadotropin for efficacy of methotrexate treatment in women with extrauterine pregnancy. Int J Gynaecol Obstet. 2012;116(2):101–104. doi: 10.1016/j.ijgo.2011.09.023.
  • van Mello NM, Mol F, Verhoeve HR, et al. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. Hum Reprod. 2013;28(1):60–67. doi: 10.1093/humrep/des373.
  • Garzon S, Raffaelli R, Montin U, et al. Primary hepatic pregnancy: report of a case treated with laparoscopic approach and review of the literature. Fertil Steril. 2018;110(5):925–931.e1. doi: 10.1016/j.fertnstert.2018.05.020.
  • Turan V. Fertility outcomes subsequent to treatment of tubal ectopic pregnancy in younger Turkish women. J Pediatr Adolesc Gynecol. 2011;24(5):251–255.
  • Jurkovic D, Memtsa M, Sawyer E, et al. Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial. Ultrasound Obstet Gynecol. 2017;49(2):171–176. doi: 10.1002/uog.17329.
  • Demirdag E, Guler I, Abay S, et al. The impact of expectant management, systemic methotrexate and surgery on subsequent pregnancy outcomes in tubal ectopic pregnancy. Ir J Med Sci. 2017;186(2):387–392. doi: 10.1007/s11845-016-1419-5.
  • Hajenius PJ, Mol F, Mol BWJ, et al. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev. 2007;2007(1):CD000324.
  • Li J, Jiang K, Zhao F. Fertility outcome analysis after surgical management of tubal ectopic pregnancy: a retrospective cohort study. BMJ Open. 2015;5(9):e007339. doi: 10.1136/bmjopen-2014-007339.
  • Juneau C, Bates GW. Reproductive outcomes after medical and surgical management of ectopic pregnancy. Clin Obstet Gynecol. 2012;55(2):455–460. doi: 10.1097/GRF.0b013e3182510a88.
  • Baggio S, Garzon S, Russo A, et al. Fertility and reproductive outcome after tubal ectopic pregnancy: comparison among methotrexate, surgery and expectant management. Arch Gynecol Obstet. 2021;303(1):259–268. doi: 10.1007/s00404-020-05749-2.
  • Elson CJ, Salim R, Potdar N, et al. Diagnosis and management of ectopic pregnancy. Int J Obstet a Gynaecol. 2016;123:e15–e55.
  • Helmy S, Sawyer E, Ofili-Yebovi D, et al. Fertility outcomes following expectant management of tubal ectopic pregnancy. Ultrasound Obstet Gynecol. 2007;30(7):988–993. doi: 10.1002/uog.5186.